KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Receivables (2016 - 2025)

Historic Receivables for Idexx Laboratories (IDXX) over the last 17 years, with Q3 2025 value amounting to $638.8 million.

  • Idexx Laboratories' Receivables rose 1155.44% to $638.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $638.8 million, marking a year-over-year increase of 1155.44%. This contributed to the annual value of $534.3 million for FY2024, which is 424.73% up from last year.
  • According to the latest figures from Q3 2025, Idexx Laboratories' Receivables is $638.8 million, which was up 1155.44% from $628.5 million recorded in Q2 2025.
  • Over the past 5 years, Idexx Laboratories' Receivables peaked at $638.8 million during Q3 2025, and registered a low of $406.1 million during Q4 2021.
  • Its 5-year average for Receivables is $502.3 million, with a median of $503.7 million in 2023.
  • Per our database at Business Quant, Idexx Laboratories' Receivables soared by 2816.23% in 2021 and then soared by 424.73% in 2024.
  • Idexx Laboratories' Receivables (Quarter) stood at $406.1 million in 2021, then grew by 8.95% to $442.5 million in 2022, then rose by 15.84% to $512.6 million in 2023, then increased by 4.25% to $534.3 million in 2024, then increased by 19.56% to $638.8 million in 2025.
  • Its last three reported values are $638.8 million in Q3 2025, $628.5 million for Q2 2025, and $590.4 million during Q1 2025.